Buscar en
Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica (English Edition) Native and prosthetic transcatheter aortic valve infective endocarditis due to L...
Journal Information
Vol. 40. Issue 7.
Pages 402-404 (August - September 2022)
Share
Share
Download PDF
More article options
Vol. 40. Issue 7.
Pages 402-404 (August - September 2022)
Scientific letter
Full text access
Native and prosthetic transcatheter aortic valve infective endocarditis due to Lactobacillus rhamnosus
Endocarditis infecciosa nativa y sobre válvula aórtica protésica transcatéter (TAVI) causada por Lactobacillus rhamnosus
Visits
145
Alba Bergasa, Samuel Riveraa, Miriam Torrecillasb, Guillermo Cuervoa,
Corresponding author
a Infectious Disease Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
b Microbiology Department, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

Lactobacillus spp. are a heterogeneous group of microaerophilic grampositive rods, commensal of the gastrointestinal and female genitourinary tracts, and often considered contaminants in blood cultures. However, cases of severe infections caused by these microorganisms have been reported.1 We report a native valve endocarditis and a spondylodiscitis with possible transcatheter aortic valve implantation (TAVI) endocarditis caused by Lactobacillus rhamnosus.

An 81-year-old male was referred for evaluation of L. rhamnosus bacteremia. He had history of TAVI implantation five months earlier and degenerative lumbar vertebra pathology, and complained of fever and one-month course of asthenia, anorexia and acute worsening of lumbar pain. Four sets of blood cultures (1 set: BACTEC™ Plus Aerobic/F and BACTEC™ Anaerobic/F, BD) were drawn on different days (two sets on the 3rd and two more on the 5th day) which were all positive after 29–42h of incubation. Gram staining showed grampositive rods that were identified as L. rhamnosus by MALDI-TOF directly from positive blood culture (score 1.8). After subculturing and incubation under anaerobic conditions, identification was further confirmed by both MALDI-TOF (score>2) and 16S rRNA gene sequencing. The 16S gene was amplified by PCR using the universal primers (27f and 907r) with conditions previously described.2 The PCR product was purified and sequenced using a BigDye terminator protocol (Applied Biosystems). Sequences were compared with BLAST (http://www.ncbi.nlm.nih.gov/BLAST) and the identification was confirmed (>99% identity) with the 16S rRNA gene sequence of L. rhamnosus LDTM7511 (GenBank accession number CP051227.1). Transesophageal echocardiography was performed and neither vegetations nor valve disfunction was observed. Treatment with ampicillin was initiated. On admission he was afebrile, with holosystolic cardiac murmur and pain at the second lumbar vertebra. Blood cultures after 48h of antibiotic treatment were negative. Antimicrobial susceptibility testing (AST) was carried out following CLSI recommendations (CLSI M45-A2) which also provides interpretative breakpoints for different antibiotics.3 MICs were determined using a broth microdilution method, SensititreTM STRHAE2 (ThermoScientific). The L. rhamnosus isolate was susceptible to penicillin (MIC 2μg/mL), ampicillin (MIC 2μg/mL), erythromycin (MIC<0.25μg/mL), clindamycin (MIC<0.25μg/mL), daptomycin (MIC1μg/mL) and linezolid (MIC<2μg/mL). The isolate did not present high-level gentamicin resistance (gentamicin MIC<500μg/mL) and was resistant to cefotaxime (MIC>2μg/mL) and vancomycin (MIC>16μg/mL). Gentamicin was added to the treatment. Positron emission tomography-computed tomography (PET-CT) showed strong 18-F fluorodeoxyglucose uptake at L1-L2 level without heart valves uptake, although performed 15 days after starting antibiotics. Diagnosis of L. rhamnosus spondylodiscitis and possible TAVI endocarditis was established (Duke criteria: 1 major microbiological criterium, and 2 minor criteria: predisposing heart condition, fever>38°C). Six weeks of treatment with ampicillin were completed, 2 of which in combination with gentamicin. The patient recovered, without relapses after a follow-up of 10 months.

An 83-year-old woman without relevant background was brought to the emergency department due to syncope. She complained of constitutional symptoms for the past six months. Physical examination showed a holosystolic murmur in mitral focus. Transthoracic echocardiogram showed a vegetation in the posterior mitral leaflet with possible valve rupture and severe mitral regurgitation. Six sets of blood cultures were positive at 26-44h of incubation (four sets the first day and two more, two days after). Microbiological diagnosis, identification and antimicrobial susceptibility testing was performed as described above in case 1. Identification by MALDI-TOF directly from the positive blood culture was unsuccessful, and L. rhamnosus was identified by MALDI-TOF (score>2) directly from colonies after subculturing, and by 16S rRNA gene analysis. The L. rhamnosus isolate was susceptible to penicillin (MIC 2μg/mL), ampicillin (MIC 4μg/mL), erythromycin (MIC<0.25μg/mL) and clindamycin (MIC<0.25μg/mL). Furthermore, the isolate did not show high-level resistance to gentamicin (gentamicin MIC<500μg/mL) as was resistant to cefotaxime (MIC>2μg/mL) and vancomycin (MIC>16μg/mL). She was admitted with the definitive diagnosis of subacute L. rhamnosus endocarditis on mitral native valve (according to Duke criteria, 2 major criteria: microbiological evidence and imaging plus 1 minor criteria: fever) and intravenous penicillin 3 MU every 4h was initiated. A whole-body PET-CT showed no pathological uptakes. Transoesophageal echocardiogram showed rupture of the posterior leaflet of mitral valve. Follow-up blood cultures at 72h of treatment were negative. The patient was considered not suitable for surgery due to advanced age and fragility. Four weeks of penicillin were completed. The patient remained asymptomatic, without relapse after 6 months of follow-up.

Although L. rhamnosus is considered a barely virulent pathogen, cases of endocarditis have been reported.1,4–8,10–20 Infective endocarditis due to Lactobacillus spp. is rare, accounting for less than 0.5% of all episodes. We only found 16 cases of L. rhamnosus endocarditis published since 1980, nevertheless some reported cases of Lactobacillus spp. endocarditis not identified at the species level could also correspond to L. rhamnosus episodes.4 After excluding a pediatric patient and two cases without available information, the 13 remaining cases are detailed in Table 1. Underlying valve disease is the most common predisposing factor, as well as prior gastrointestinal o dental manipulations.5,6 Consumption of probiotics is also considered a potential risk factor,7,8 as specifically described in 6 cases (46.2%). The most frequently affected valve is the aortic (n=9, 69.2%), followed by mitral (n=3, 23.1%). Whereas only three cases (23.1%) involved prosthetic valves, most native valves were anatomically or functionally abnormal.

Table 1.

Infective endocarditis (IE) due to Lactobacillus rhamnosus: summary of case reports.

Author, publication date  Age, sex  Predisposing factors for bacteremia or IE  Consumption of probiotics  Valve/vertebra involved  Antibiotics  Surgery  Outcome 
Davies et al., 198612  55, M  UK  No  Aortic valve  Penicillin, gentamicin  Yes  Cured 
Holliman et al., 198813  71, F  Prosthetic aortic valve  UK  Prosthetic aortic valve  UK  UK  Death 
Griffiths et al., 199214  45, M  Bicuspid aorta; Dental manipulation  No  Bicuspid aorta  Ampicillin, gentamicin  Yes  Cured 
Mackay et al., 19997  67, M  Mitral valve prolapse with regurgitation  Yes  Mitral valve  Ampicillin, gentamicin  No  Cured 
Presterl et al., 200115  23, M  Bicuspid aorta  Yes  Bicuspid aorta  Penicillin  Yes  Cured 
Avlami et al., 20016  65, M  Colonoscopy  No  Aortic valve  Penicillin, gentamicin  No  Cured 
Wallet et al., 200216  73, M  Prosthetic aortic valve  No  Mitral valve  Amoxicillin, rifampin  Yes  Cured 
Kochan et al., 20118  24, F  Prosthetic aortic valve  Yes  Prosthetic aortic valve  UK  Yes  Cured 
Felekos et al., 201417  74, M  Myxomatous mitral valve  No  Myxomatous mitral valve  Penicillin, gentamicin  Yes  Cured 
Aaron et al., 20175  80, M  Upper endoscopy  No  Aortic and mitral valve  Penicillin, gentamicin  Yes  Cured 
Noreña et al., 201718  28, M  Bicuspid aorta  Yes  Bicuspid aorta  Ampicillin, gentamicin  Yes  Cured 
Boumis et al., 201819  65, M  Hereditary hemorrhagic telangiectasia  Yes  Prosthetic aortic valve  Amoxicillin/clavulanate, gentamicin  No  Cured 
Naqvi et al., 201820  36, F  Cirrhosis  Yes  Aortic valve  Penicillin, gentamicin  Yes  Death 

UK: unknown, not specified in this manuscript.

Closely related, Lactobacillus species are difficult to identify by conventional methods, including MALDI-TOF MS. Therefore, molecular techniques such as 16S rRNA sequencing might be used in combination to achieve a more reliable identification. We suggest that the lack of genus-specific clinical breakpoints for Lactobacillus spp. is a challenge for interpretation of antimicrobial susceptibility testing. For example, EUCAST categorizes this gender into a global grampositive anaerobes group9 and CLSI only defines breakpoints for a few antimicrobials against Lactobacillus spp. In this sense, further studies are required in order to develop reproducible and definitive standards to interpret susceptibility results.

Even though there is no standard treatment, most reports suggest the combination of ampicillin with aminoglycosides. Combination treatment was reported in 10 out of the 13 reviewed cases (76.9%), and surgical intervention was required in 9 cases (69.2%), 8 native and 1 prosthetic valve episodes, most of them operated not during the active phase of treatment (e.g. early valve surgery) but rather to correct the mechanical sequelae with valve dysfunction after finishing antibiotics.

Strains with decreased susceptibility to ampicillin have been found, emphasizing that minimal inhibitory concentration of beta-lactam antibiotics as well as the exclusion of high-level resistance to aminoglycosides are relevant investigations. Eleven patients (84.6%) were cured and 2 (15.4%) died during hospitalization. Only 2 cases of spondylodiscitis have been reported, and one of them was a polymicrobial infection secondary to esophagus perforation. Both cases presented epidural abscess, one requiring surgery and no endocarditis association was described.10,11

No previous cases of TAVI endocarditis and spondylodiscitis have been published up to now. Our report underscores the potential clinical significance of L. rhamnosus bacteremia, highlighting the need for further investigations in patients with an elusive source of the infection.

References
[1]
J.P. Cannon, T.A. Lee, J.T. Bolanos, L.H. Danziger.
Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases.
Eur J Clin Microbiol Infect Dis, 24 (2005), pp. 31-40
[2]
D.-P. Mao, Q. Zhou, C.-Y. Chen, Z.-X. Quan.
Coverage evaluation of universal bacterial primers using the metagenomic datasets.
BMC Microbiol, 12 (2012), pp. 66
[3]
Clinical and Laboratory Standards Institute (CLSI). Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline-second edition. CLSI document M45-A2. Wayne, PA: CLSI; 2011.
[4]
E.M.T. Salvana, M. Frank.
Lactobacillus endocarditis: case report and review of cases reported since 1992.
[5]
J.G. Aaron, M.E. Sobieszczyk, S.D. Weiner, S. Whittier, F.D. Lowy.
Lactobacillus rhamnosus endocarditis after upper endoscopy.
Open Forum Infect Dis, 4 (2017), pp. otx085
[6]
A. Avlami, T. Kordossis, N. Vrizidis, N.V. Sipsas.
Lactobacillus rhamnosus endocarditis complicating colonoscopy.
J Infect, 42 (2001), pp. 283-285
[7]
A.D. Mackay, M.B. Taylor, C.C. Kibbler, J.M.T. Hamilton-Miller.
Lactobacillus endocarditis caused by a probiotic organism.
Clin Microbiol Infect, 5 (1999), pp. 290-292
[8]
P. Kochan, A. Chmielarczyk, L. Szymaniak, M. Brykczynski, K. Galant, A. Zych, et al.
Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient-is the time right to revise probiotic safety guidelines?.
Clin Microbiol Infect, 17 (2011), pp. 1589-1592
[9]
The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0, 2021. http://www.eucast.org.
[10]
S. Metcalfe, C. Morgan-Hough.
Cervical epidural abscess and vertebral osteomyelitis following non-traumatic oesophageal rupture: a case report and discussion.
Eur Spine J, 18 (2009), pp. 224-227
[11]
H. Pailhoriès, D. Sanderink, P. Abgueguen, C. Lemarié.
Un pathogène rare responsable d’infections profondes : un cas clinique de spondylodiscite due à Lactobacillus spp Vol. 47 Medecine et Maladies Infectieuses.
Elsevier Masson SAS, (2017), pp. 302-303
[12]
A.J. Davies, P.A. James, P.M. Hawkey.
Lactobacillus endocarditis.
J Infect, 12 (1986), pp. 169-174
[13]
R.E. Holliman, G.P. Bone.
Vancomycin resistance of clinical isolates of lactobacilli.
J Infect, 16 (1988), pp. 279-283
[14]
J.K. Griffiths, J.S. Daly, R.A. Dodge.
Two cases of endocarditis due to Lactobacillus species: Antimicrobial susceptibility, review, and discussion of therapy.
Clin Infect Dis, 15 (1992), pp. 250-255
[15]
E. Presterl, W. Kneifel, H.K. Mayer, M. Zehetgruber, A. Makristathis, W. Graninger.
Endocarditis by Lactobacillus rhamnosus due to Yogurt ingestion?.
Scand J Infect Dis, 33 (2001), pp. 710-714
[16]
F. Wallet, R. Dessein, S. Armand, R.J. Courcol.
Molecular diagnosis of endocarditis due to Lactobacillus casei subsp. rhamnosus.
Clin Infect Dis, 35 (2002), pp. 117-119
[17]
I. Felekos, G. Lazaros, A. Tsiriga, M. Pirounaki, G. Stavropoulos, J. Paraskevas, et al.
Lactobacillus rhamnosus endocarditis: an unusual culprit in a patient with Barlow's disease.
Hell J Cardiol, 57 (2016), pp. 445-448
[18]
I. Noreña, O. Cabrera-Marante, M. Fernández-Ruiz.
Endocarditis due to Lactobacillus rhamnosus in a patient with bicuspid aortic valve: Potential role for the consumption of probiotics?.
Med Clin (Barc), 149 (2017), pp. 181-182
[19]
E. Boumis, A. Capone, V. Galati, C. Venditti, N. Petrosillo.
Probiotics and infective endocarditis in patients with hereditary hemorrhagic telangiectasia: a clinical case and a review of the literature.
BMC Infect Dis, 18 (2018), pp. 1-8
[20]
S.S.B. Naqvi, V. Nagendra, A. Hofmeyr.
Probiotic related Lactobacillus rhamnosus endocarditis in a patient with liver cirrhosis.
IDCases, 13 (2018), pp. e00439
Copyright © 2021. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos